Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema
Authors:
Open Access
- 1 January 2005
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (1) , 122
Abstract
The clinical interventional case series study included four patients with diffuse diabetic macular oedema who consecutively received a second intravitreal injection of about 20 mg triamcinolone acetonide 7.6 (SD 3.9) months (median, 6.7 months; range, 4.1–13.1 months) after the first injection, and for whom follow up was longer than 3 months. The second injection was carried out, since visual acuity had decreased again after an initial increase following the first intravitreal injection. Mean follow up after the second injection was 5.6 (SD 4.2) months (median 5.6 months; range 1–10.5 months). Mean age of the patients was 62.0 (5.0) years (range 56.8–67.8 years; median 61.7 years), refractive error ranged between a mean of −0.75 (SD 1.19) dioptres and +2.50 (1.38) dioptres. All patients were fully informed about the experimental character of the therapy and had signed an informed consent. The ethics committee of the university had approved the study. All patients received an intravitreal injection of about 20 mg triamcinolone acetonide in 0.2 ml Ringer’s solution as previously described in detail.4Keywords
This publication has 5 references indexed in Scilit:
- Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edemaAmerican Journal of Ophthalmology, 2004
- Intravitreal Reinjection of Triamcinolone for Exudative Age-RelatedMacular DegenerationArchives of Ophthalmology (1950), 2004
- Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionOphthalmology, 2003
- Intravitreal triamcinolone for refractory diabetic macular edemaOphthalmology, 2002
- Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group.1991